Patient-reported outcomes and the management of prostate cancer

Andrew Vickers, PhD, who works at the Memorial Sloan-Kettering Cancer Center in New York, is not a physician. He is a statistician and a research methodologist. And he is a member of the Scientific Advisory Board to The “New” Prostate Cancer InfoLink. … READ MORE …

The future of focal therapy

Two “pro” and “con” commentaries appeared on line this week in the Journal of Urology under the heading “Focal therapy will become standard treatment for localized prostate cancer.” .. READ MORE …

Effect of the Prosdex decision support tool on attitudes to PSA testing

In the UK, a nationally developed, on-line decision support tool known as Prosdex is available and is used by at least some men to help them make decisions about whether they wish to undergo PSA testing. … READ MORE …